Literature DB >> 27865293

Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach.

Tolga Aksu1, Tumer Guler2, Kivanc Yalin3, Sukriye Ebru Golcuk3, Kazim Ozcan2.   

Abstract

Septal reduction therapy is the gold standard treatment method for symptomatic, hypertrophic obstructive cardiomyopathy. Although surgical myectomy is a well-established and effective technique with decades of experience in its application, use of transcoronary alcohol septal ablation has increased precipitously owing to the less-invasive nature of the procedure. Moreover, endocardial septal ablation therapy is a relatively newly defined modality, and outcomes of the procedure are not clearly elucidated yet. In this review, we aimed to present nonsurgical septal reduction approaches in patients with hypertrophic obstructive cardiomyopathy.
Copyright © 2016 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablation; Alcohol septal ablation; Hypertrophic obstructive cardiomyopathy; Radiofrequency; Septal myectomy

Mesh:

Year:  2016        PMID: 27865293     DOI: 10.1016/j.amjms.2016.08.025

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  1 in total

1.  Septal Ablation with Radiofrequency Catheters Guided by Echocardiography for Treatment of Patients with Obstructive Hypertrophic Cardiomyopathy: Initial Experience.

Authors:  Bruno P Valdigem; Edileide B Correia; Dalmo A R Moreira; David Le Bihan; Ibraim Masciarelli Francisco Pinto; Alexandre A Cunha Abizaid; Rogério Braga Andalaft; Antonio Tito Paladino Filho; Halstead Alarcão Gomes Pereira da Silva; Joao Henrique Zucco Viesi
Journal:  Arq Bras Cardiol       Date:  2022-05       Impact factor: 2.667

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.